Skip to content
Recall Observatory FDA recall evidence

Drug product

Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by: Ajanta Pharma USA Inc. Bridgewater, NJ 08807, NDC 27241-120-04.

D-0611-2026

May 28, 2026

Class II

Product summary

Firm
Ajanta Pharma USA Inc
Event
Event 99130
Status
Ongoing
Classification
Class II
Quantity
3648 bottles
Official record key
drug-enforcement:D-0611-2026

Official wording

Reason: CGMP Deviations

Code information: Lot # PA02216; Exp. 12/2029

Distribution pattern: U.S. Nationwide

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations